Gardner Lewis Asset Management L P Horizon Therapeutics Public LTD CO Transaction History

Gardner Lewis Asset Management L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $13 Million - $15.2 Million	131,142 New	131,142 $15.2 Million
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $4.13 Million - $4.37 Million	38,500 Added 171.11%	61,000 $6.66 Million
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $1.4 Million - $2.56 Million	22,500 New	22,500 $2.56 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Gardner Lewis Asset Management L P with notifications on news.